FreeStyle Libre 2 is now reimbursed under the RAMQ
Abbott today announced that its FreeStyle Libre 2 flash glucose monitoring system is now reimbursed under the Régie de l’assurance maladie du Quebec (RAMQ) for Quebec residents aged four and over who manage their diabetes (type 1 or type 2) with multiple daily injections of insulin. Quebec was one of the first Canadian provinces to reimburse flash glucose monitoring technology and with the addition of FreeStyle Libre 2, families with children who are living with diabetes will have the opportunity to benefit from this important diabetes management tool.
The FreeStyle Libre 2 system represents a significant advancement in diabetes management for Canadians. The sensor, which is the size of a Canadian Toonie, is worn on the back of the upper arm for up to 14 days. It measures glucose every minute to help people living with diabetes and their healthcare team make informed treatment decisions. With a one-second scan of a smartphone using the FreeStyle Libre 2 app,α users can see their glucose reading, trend arrow and eight-hour history. Using Bluetooth technology, the FreeStyle Libre 2 system can automaticallyπ alert users when their glucose is too high or low without needing to scan the sensor. Users can also share data with their family members via the LibreLinkUp mobile app.
“This is great news for those living with diabetes in Quebec,” said Sylvie Lauzon, president and CEO, Diabète Québec. “Providing access to flash glucose monitoring can help improve a person living with diabetes’ ability to self-monitor, which is key to better diabetes management, and which can really help improve the quality of life of people living with diabetes.”
